Teva Pharmaceutical Industries Limited (TEV) — Free Cash Flow Generation Index
Teva Pharmaceutical Industries Limited (TEV) has a Free Cash Flow Generation Index of 0.88x as of December 2025. Free cash flow of €1.02 Billion represents 1% of operating cash flow (€1.16 Billion). Explore reinvestment intensity of Teva Pharmaceutical Industries Limited to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Limited Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Teva Pharmaceutical Industries Limited across 11 annual periods. For the full cash flow conversion analysis, see TEV cash flow conversion.
Annual Free Cash Flow Generation for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year Free Cash Flow Generation Index for Teva Pharmaceutical Industries Limited. Check Teva Pharmaceutical Industries Limited (TEV) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | €1.15 Billion | €1.65 Billion | €501.00 Million | ▲ +15.9% |
| 2024 | 0.60x | €749.00 Million | €1.25 Billion | €498.00 Million | ▲ +14.3% |
| 2023 | 0.53x | €608.00 Million | €1.16 Billion | €549.00 Million | ▼ -19.8% |
| 2022 | 0.66x | €1.04 Billion | €1.59 Billion | €548.00 Million | ▲ +121.6% |
| 2021 | 0.30x | €236.00 Million | €798.00 Million | €562.00 Million | ▼ -43.6% |
| 2020 | 0.52x | €638.00 Million | €1.22 Billion | €578.00 Million | ▲ +76.0% |
| 2019 | 0.30x | €223.00 Million | €748.00 Million | €525.00 Million | ▼ -59.4% |
| 2018 | 0.73x | €1.79 Billion | €2.45 Billion | €651.00 Million | ▼ -38.0% |
| 2017 | 1.18x | €2.63 Billion | €2.23 Billion | €874.00 Million | ▼ -3.9% |
| 2016 | 1.23x | €4.79 Billion | €3.89 Billion | €901.00 Million | ▲ +8.1% |
| 2015 | 1.14x | €6.31 Billion | €5.54 Billion | €772.00 Million | — |